BackShandong Weigao Group Medical Polymer Company Limited Overview
Shandong Weigao Group Medical Polymer Company Limited

Shandong Weigao Group Medical Polymer Company Limited Return on Equity

Valuation check: SHWGY's ROE is 13.63%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

13.63%

Return on Equity

13.63%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Shandong Weigao Group Medical Polymer Company Limited (SHWGY) FAQ

The latest ROE for SHWGY is 13.63%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Shandong Weigao Group Medical Polymer Company Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SHWGY currently prints 13.63% for ROE, while the sector average sits near 11.3%. That is roughly 20.7% above the sector mean. Large gaps often invite a closer look at Shandong Weigao Group Medical Polymer Company Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively Shandong Weigao Group Medical Polymer Company Limited converts resources into returns. At 13.63%, SHWGY may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SHWGY's ROE (13.63%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.